Single-dose universal hepatitis a immunization in Argentina: Low viral circulation and high persistence of protective antibodies up to 4 years

Journal of the Pediatric Infectious Diseases Society

Volumn 4, Issue 4, 2015, Pages e62-e67

  Vizzotti, C ^a   Gonzalez J ^b   Rearte, A ^a   Urueña, Analía ^a   Perez Carrega M ^a   Calli, R ^c   Gentile, A ^d   Uboldi, A ^e   Ramonet, M ^f   Canero Velasco M ^g   Diosque, M ^a  

^a National Ministry of Health   (Argentina)

^b INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^c Programa Ampliado de Inmunizaciones   (Argentina)

^d HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^e Ministerio de Salud de la Provincia de Santa Fe   (Argentina)

^f HOSPITAL NACIONAL PROFESOR ALEJANDRO POSADAS   (Argentina)

^g Hospital de Ninos de San Justo   (Argentina)

Author keywords

Argentina; Hepatitis A; Immunogenicity; Single dose vaccination; Viral circulation

Indexed keywords

HEPATITIS A VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; HEPATITIS A ANTIBODY;

ARGENTINA; ARTICLE; BLOOD ANALYSIS; CHILD; EDUCATION; FEMALE; HEPATITIS A; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFANT; MALE; PRIORITY JOURNAL; SEROPREVALENCE; SINGLE DRUG DOSE; VIRUS TRANSMISSION; BLOOD; PRESCHOOL CHILD; SEROEPIDEMIOLOGY;

ARGENTINA; CHILD, PRESCHOOL; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HUMANS; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; MALE; SEROEPIDEMIOLOGIC STUDIES;

EID: 85006184883     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/piu068     Document Type: Article

References (42)

1. Koff RS. Hepatitis A. Lancet 1998; 351:1643-9.
2. Vildózola Gonzáles H. Active immunization against hepatitis A [in Spanish]. Rev Gastroenterol Peru 2001; 21:3 Lima jul/set.
3. World Health Organization. The Immunological Basis for Immunization Series. Module 18: Hepatitis A. 2011. Available at: http://whqlibdoc.who.int/publications/2011/97892415014 22_eng.pdf. Accessed 1 October 2013.
4. National Census of Population Households and Dwellings in 2001, Argentina [in Spanish]. Available at: http://www.indec. mecon.ar/micro_sitios/webcenso/censo2001s2/ampliada_index. asp?mode=01. Accessed 27 June 2014.
5. National Census of Population Households and Dwellings in 2010, Argentina [in Spanish]. Available at: http://www. censo2010.indec.gov.ar/. Accessed 1 October 2013.
6. Gonzalez J, Fay O, Cañero-Velasco M, et al. Virus infection of hepatitis A (HAV) in children in Argentina. Pilot trial [in Spanish]. Acta Gastroent Latinoamer 1997; 27(5).
7. Findor JA, Cañero-Velasco MC, Mutti J, Safari A. Response to hepatitis A vaccine in children after a single dose with booster administration 6 months later. J Travel Med 1996; 3:156-9.
8. Werzberger A, Mensch B, Kuter B, et al. A controlled trial of formalin-inactivated hepatitis a vaccine in healthy children. N Engl J Med 1992; 327:453-7.
9. López EL, Contrini MM, Xifró MC, et al. Hepatitis Avaccination of Argentinean infants: comparison of two vaccination schedules. Vaccine 2007; 25:102-8.
10. Mayorga Pérez O, Herzog C, Zellmeyer M, et al. Efficacy of virosome hepatitis a vaccine in young children in Nicaragua: randomized placebo-controlled trial. J Infect Dis 2003; 188: 671-7.
11. Averhoff F, Shapiro C, Bell B, et al. Control of hepatitis A through routine vaccination of children. JAMA 2001; 286:2968-73.
12. Wasley A, Samandari T, Bell B. Incidence of HAV in the United States in the era of vaccination. JAMA 2005; 294:194-201.
13. Dagan R, Leventhal A, Anis E, et al. Incidence of hepatitis A in Israel following universal immunization in toddlers. JAMA 2005; 294:202-10.
14. Fangcheng Z, Xuanyi W, Mingding C, et al. Era of vaccination heralds a decline in incidence of hepatitis A in high risk groups in China. Hepat Mon 2012; 12:100-5.
15. Ministerio de Salud y Ambiente, Argentina. Resolución 653/05, 113(30677). Buenos Aires, Argentina: Boletín Oficial de la República Argentina, 2005. pp 3.
16. Gentile A, Ramonet M, Ellis A. Analysis on the necessity of the introduction of the vaccine against hepatitis A in the Argentina. National Committee of Infectious Diseases, Sociedad Argentina de Pediatría [in Spanish]. Arch Argent Pediatr 2004; 102:487-98.
17. Ciocca M, Moreira-Silva SF, Alegría S, et al. Hepatitis A as an etiologic agent of acute liver failure in Latin America. Pediatr Infect Dis J 2007; 26:711-15.
18. Ciocca M, Ramonet M, Cuarterolo M, et al. Acute liver failure in children: experience with 210 patients. J Pediatr Gastroenterol Nutr 2004; 39(Suppl 1):pS31.
19. Ciocca M, Ramonet M, Cuarterolo M, et al. Prognostic factors in pediatric acute liver failure. Arch Dis Child 2008; 93:48-51.
20. Hatz C, van der Ploeg R, Beck B, et al. Successful memory response following a booster dose with a virosome-formulated hepatitis A vaccine delayed up to 11 years. Clin Vaccine Immunol 2011; 18:884-7.
21. Gentile A. The need for an evidence-based decision-making process with regard to control of hepatitis A. J Viral Hepat 2008; 15 (Suppl 2):16-21.
22. Vacchino MN. Incidence of hepatitis A in Argentina after vaccination. J Viral Hepat 2008; 15(Suppl 2):47-50.
23. Cervio G, Trentadue J, D'Agostino D, et al. Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program. Hepat Med 2011; 3 99-106.
24. Vizzotti C, Gonzalez J, Gentile A, et al. Impact of the single dose immunization strategy against hepatitis A in Argentina. Pediatr Infect Dis J 2014; 33:84-8.
25. Barkai G, Belmaker I, Givon-Lavi N, Dagan R. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers. Pediatr Infect Dis J 2009; 28:391-3.
26. Chan CY, Lee SD, Yu MI, et al. Long-term follow up of hepatitis A vaccination in children. Vaccine 1999; 17:369-72.
27. Fan PC, Chang MH, Lee PI, et al. Follow-up immunogenicity of an inactivated hepatitis Avirus vaccine in healthy children: results after 5 years. Vaccine 1998; 16:232-5.
28. Van Damme P, Thoelen S, Cramm M, et al. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence. J Med Virol 1994; 44:446-51.
29. López H, Zitto T, Baré P, et al. Prevalence of anti-hepatitis A antibodies in an urban middle class area of Argentina: some associated factors. Int J Infect Dis 2000; 4:34-7.
30. Fiore A, Wasley A, Bell B. Prevention of hepatitis A through active or passive immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55(RR-7):1-23.
31. Feinstone S, Gust I. Hepatitis A virus. In: Mandell G, Bennett J, Dolin R, ed. Principles and Practice of Infectious Diseases. 5th ed. Vol. 2. Churchill Livingstone. 2000: pp 1920-40.
32. Espul C, Benedetti L, Cuello H, et al. Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina. Hepat Med 2012; 4:53-60.
33. Blanco M, Torres C, Riviello-López G, et al. Analysis of the circulation of hepatitis A virus in Argentina since vaccine introduction. Clin Microbiol Infect 2012; 18:E548-51.
34. Yanez L, Lucero N, Barril P, et al. Evidence of hepatitis A virus circulation in central Argentina: seroprevalence and environmental surveillance. J Clin Virol 2014; 59:38-43.
35. Landry P, Tremblay S, Darioli R, Genton B. Inactivated hepatitis a vaccine booster given ≥24 months after the primary dose. Vaccine 2001; 19:399-402.
36. Beck BR, Hatz C, Brönimann R, Herzog C. Successful booster antibody response up to 54 months after single primary vaccination with virosome-formulated, aluminum-free hepatitis A vaccine. Clin Infect Dis 2003; 37:e126-8.
37. Iwarson S, Lindh M, Widerström L. Excellent booster response 4-6 y after a single primary dose of an inactivated hepatitis A vaccine. Scand J Infect Dis 2002; 34:110-1.
38. Ott J, Wiersma S. Single-dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations. Int J Infect Dis 2013; 17 :e939-44.
39. Fiore AE, Shapiro CN, Sabin K, et al. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose. Pediatr Infect Dis J 2003; 22: 354-9.
40. Van Damme P, Banatvala J, Fay O, et al. Hepatitis A booster vaccination: is there a need? Lancet 2003; 362:1065-71.
41. Fangcheng Z, Xuanyi W, Mingding C, et al. Era of vaccination heralds a decline in incidence of hepatitis a in high risk groups in China. Hepat Mon 2012; 12:100-5.
42. Xu ZY, Li ZH, Wang JX, et al. Ecology and prevention of shellfish-associated hepatitis A epidemic in Shangai, China. Vaccine 1992; 10(Suppl 1):S67-8.